Cargando…

Alpha synuclein in hematopoiesis and immunity

Parkinson's disease (PD) is the second most common neurodegenerative condition and intracellular deposition of Lewy bodies in the substantia nigra (SN), which can cause dopaminergic neuronal death, is the hallmark of this syndrome. α-synuclein (syn) is a small protein expressed mainly in neuron...

Descripción completa

Detalles Bibliográficos
Autores principales: Pei, Yu, Maitta, Robert W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806402/
https://www.ncbi.nlm.nih.gov/pubmed/31692680
http://dx.doi.org/10.1016/j.heliyon.2019.e02590
_version_ 1783461620418084864
author Pei, Yu
Maitta, Robert W.
author_facet Pei, Yu
Maitta, Robert W.
author_sort Pei, Yu
collection PubMed
description Parkinson's disease (PD) is the second most common neurodegenerative condition and intracellular deposition of Lewy bodies in the substantia nigra (SN), which can cause dopaminergic neuronal death, is the hallmark of this syndrome. α-synuclein (syn) is a small protein expressed mainly in neurons but can also be found in a number of tissues. It can be present as a soluble monomer under normal physiological conditions, but can be toxic in its oligomeric or fibrillary forms. Most of the available literature has focused on the effects of α-syn pathology in the mechanisms leading to PD. However, the normal functions of α-syn still remain to be fully elucidated. Notably, α-syn in the hematopoietic system seems to mediate important functions as indicated by anemia and incomplete cell maturation when this protein is absent. This review will summarize basic genetic and structural findings, and critical information that suggests an essential role of α-syn in the development and activation of the hematopoietic system and immunity.
format Online
Article
Text
id pubmed-6806402
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-68064022019-11-05 Alpha synuclein in hematopoiesis and immunity Pei, Yu Maitta, Robert W. Heliyon Article Parkinson's disease (PD) is the second most common neurodegenerative condition and intracellular deposition of Lewy bodies in the substantia nigra (SN), which can cause dopaminergic neuronal death, is the hallmark of this syndrome. α-synuclein (syn) is a small protein expressed mainly in neurons but can also be found in a number of tissues. It can be present as a soluble monomer under normal physiological conditions, but can be toxic in its oligomeric or fibrillary forms. Most of the available literature has focused on the effects of α-syn pathology in the mechanisms leading to PD. However, the normal functions of α-syn still remain to be fully elucidated. Notably, α-syn in the hematopoietic system seems to mediate important functions as indicated by anemia and incomplete cell maturation when this protein is absent. This review will summarize basic genetic and structural findings, and critical information that suggests an essential role of α-syn in the development and activation of the hematopoietic system and immunity. Elsevier 2019-10-18 /pmc/articles/PMC6806402/ /pubmed/31692680 http://dx.doi.org/10.1016/j.heliyon.2019.e02590 Text en © 2019 Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Pei, Yu
Maitta, Robert W.
Alpha synuclein in hematopoiesis and immunity
title Alpha synuclein in hematopoiesis and immunity
title_full Alpha synuclein in hematopoiesis and immunity
title_fullStr Alpha synuclein in hematopoiesis and immunity
title_full_unstemmed Alpha synuclein in hematopoiesis and immunity
title_short Alpha synuclein in hematopoiesis and immunity
title_sort alpha synuclein in hematopoiesis and immunity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806402/
https://www.ncbi.nlm.nih.gov/pubmed/31692680
http://dx.doi.org/10.1016/j.heliyon.2019.e02590
work_keys_str_mv AT peiyu alphasynucleininhematopoiesisandimmunity
AT maittarobertw alphasynucleininhematopoiesisandimmunity